A share price of Progyny Inc [PGNY] is currently trading at $15.44, up 3.14%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The PGNY shares have gain 12.13% over the last week, with a monthly amount drifted -0.71%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Progyny Inc [NASDAQ: PGNY] stock has seen the most recent analyst activity on November 13, 2024, when Truist downgraded its rating to a Hold and also revised its price target to $19 from $26. Previously, JMP Securities downgraded its rating to Mkt Perform on September 19, 2024. On August 07, 2024, downgrade downgraded it’s rating to Market Perform and revised its price target to $25 on the stock. Canaccord Genuity downgraded its rating to a Hold and decreased its price target to $24 on August 07, 2024. BTIG Research downgraded its rating to a Neutral. JMP Securities started tracking with a Mkt Outperform rating for this stock on July 16, 2024, and assigned it a price target of $36. In a note dated May 10, 2024, KeyBanc Capital Markets downgraded an Sector Weight rating on this stock.
Progyny Inc experienced fluctuations in its stock price throughout the past year between $13.39 and $42.08. Currently, Wall Street analysts expect the stock to reach $25.29 within the next 12 months. Progyny Inc [NASDAQ: PGNY] shares were valued at $15.44 at the most recent close of the market. An investor can expect a potential return of 63.8% based on the average PGNY price forecast.
Analyzing the PGNY fundamentals
Trailing Twelve Months sales for Progyny Inc [NASDAQ:PGNY] were 1.14B which represents 2.04% growth. Gross Profit Margin for this corporation currently stands at 0.22% with Operating Profit Margin at 0.06%, Pretax Profit Margin comes in at 0.07%, and Net Profit Margin reading is 0.05%. To continue investigating profitability, this company’s Return on Assets is posted at 0.09, Equity is 0.11 and Total Capital is 0.15. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.04.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 15.09 points at the first support level, and at 14.74 for the second support level. However, for the 1st resistance point, the stock is sitting at 15.75, and for the 2nd resistance point, it is at 16.06.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Progyny Inc [NASDAQ:PGNY] is 2.62. As well, the Quick Ratio is 2.62, while the Cash Ratio is 0.44. Considering the valuation of this stock, the price to sales ratio is 1.19, the price to book ratio is 3.14 and price to earnings (TTM) ratio is 26.60.
Transactions by insiders
Recent insider trading involved Sturmer Michael E, PRESIDENT, that happened on Jul 16 ’24 when 9030.0 shares were sold. Director, Scott Cheryl completed a deal on Jun 28 ’24 to sell 1462.0 shares. Meanwhile, PRESIDENT Sturmer Michael E sold 4515.0 shares on May 01 ’24.
